Pharmaceutical composition for the sustained release of...

Details Pharmaceutical composition for the sustained release of... Pharmaceutical composition for the sustained release of...

A - Human Necessities

61

K

A61K 9/22 (2006.01)

Patent

CA 2579220

The invention relates to a sustained release form of hydralazine for use in cancer therapy. Said sustained release form of hydralazine can be used to obtain a constant concentration of the active principle in the blood, thereby enabling the demethylating effect of the hydralazine without producing the hypotensive action thereof, such that the inventive composition can be used in cancer therapy.

L'invention concerne une formulation à libération prolongée d'hydralazine destinée à être utilisée dans le traitement du cancer. Cette formulation à libération prolongée d'hydralazine permet d'atteindre une concentration constante du principe actif dans le sang de façon à produire l'effet déméthylant de l'hydralazine sans que se manifeste son action d'hypotension, ce qui permet d'utiliser ladite formulation à libération prolongée d'hydralazine dans le traitement du cancer.

Affiliated with

Also associated with

Rating

Pharmaceutical composition for the sustained release of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for the sustained release of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the sustained release of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1651485